Literature DB >> 17306850

Activation of protein kinase C and disruption of endothelial monolayer integrity by sodium arsenite--Potential mechanism in the development of atherosclerosis.

Flavia E Pereira1, J Douglas Coffin, Howard D Beall.   

Abstract

Arsenic exposure has been shown to exacerbate atherosclerosis, beginning with activation of the endothelium that lines the vessel wall. Endothelial barrier integrity is maintained by proteins of the adherens junction (AJ) such as vascular endothelial cadherin (VE-cadherin) and beta-catenin and their association with the actin cytoskeleton. In the present study, human aortic endothelial cells (HAECs) were exposed to 1, 5 and 10 microM sodium arsenite [As(III)] for 1, 6, 12 and 24 h, and the effects on endothelial barrier integrity were determined. Immunofluorescence studies revealed formation of actin stress fibers and non-uniform VE-cadherin and beta-catenin staining at cell-cell junctions that were concentration- and time-dependent. Intercellular gaps were observed with a measured increase in endothelial permeability. In addition, concentration-dependent increases in tyrosine phosphorylation (PY) of beta-catenin and activation of protein kinase Calpha (PKCalpha) were observed. Inhibition of PKCalpha restored VE-cadherin and beta-catenin staining at cell-cell junctions and abolished the As(III)-induced formation of actin stress fibers and intercellular gaps. Endothelial permeability and PY of beta-catenin were also reduced to basal levels. These results demonstrate that As(III) induces activation of PKCalpha, which leads to increased PY of beta-catenin downstream of PKCalpha activation. Phosphorylation of beta-catenin plausibly severs the association of VE-cadherin and beta-catenin, which along with formation of actin stress fibers, results in intercellular gap formation and increased endothelial permeability. To the best of our knowledge, this is the first report demonstrating that As(III) causes a loss of endothelial monolayer integrity, which potentially could contribute to the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306850      PMCID: PMC1884128          DOI: 10.1016/j.taap.2006.12.035

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  42 in total

Review 1.  Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system.

Authors:  G P van Nieuw Amerongen; V W van Hinsbergh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-03       Impact factor: 8.311

2.  Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan.

Authors:  Chin-Hsiao Tseng; Choon-Khim Chong; Ching-Ping Tseng; Yu-Mei Hsueh; Hung-Yi Chiou; Ching-Chung Tseng; Chien-Jen Chen
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

Review 3.  Structural and functional aspects of intercellular junctions in vascular endothelium.

Authors:  H J Schnittler
Journal:  Basic Res Cardiol       Date:  1998       Impact factor: 17.165

4.  A mouse model for the study of vascular permeability changes induced by arsenic.

Authors:  Ming-Hsien Tsai; Shih-Chieh Chen; Hsiu-Jen Wang; Hsin-Su Yu; Louis W Chang
Journal:  Toxicol Mech Methods       Date:  2005       Impact factor: 2.987

5.  Hypertension and arsenic exposure in Bangladesh.

Authors:  M Rahman; M Tondel; S A Ahmad; I A Chowdhury; M H Faruquee; O Axelson
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

6.  Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells.

Authors:  A Barchowsky; E J Dudek; M D Treadwell; K E Wetterhahn
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 7.  Organization and function of stress fibers in cells in vitro and in situ. A review.

Authors:  H R Byers; G E White; K Fujiwara
Journal:  Cell Muscle Motil       Date:  1984

8.  Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways.

Authors:  A Barchowsky; R R Roussel; L R Klei; P E James; N Ganju; K R Smith; E J Dudek
Journal:  Toxicol Appl Pharmacol       Date:  1999-08-15       Impact factor: 4.219

Review 9.  Cytokines in atherosclerosis: pathogenic and regulatory pathways.

Authors:  Alain Tedgui; Ziad Mallat
Journal:  Physiol Rev       Date:  2006-04       Impact factor: 37.312

10.  Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice.

Authors:  Petia P Simeonova; Tracy Hulderman; Dan Harki; Michael I Luster
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

View more
  5 in total

Review 1.  Cadmium in Human Diseases: It's More than Just a Mere Metal.

Authors:  Ghizal Fatima; Ammar Mehdi Raza; Najah Hadi; Nitu Nigam; Abbas Ali Mahdi
Journal:  Indian J Clin Biochem       Date:  2019-06-27

2.  Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage.

Authors:  Yunlun Li; Xinya Zhang; Wenqing Yang; Chao Li; Yanjun Chu; Haiqiang Jiang; Zhenzhen Shen
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

3.  Arsenite exposure compromises early embryonic development in the Golden hamster.

Authors:  Dave Unis; Cassandra Osborne; Moussa M Diawara
Journal:  Reprod Toxicol       Date:  2009-05-15       Impact factor: 3.143

Review 4.  The vascular system as a target of metal toxicity.

Authors:  Walter C Prozialeck; Joshua R Edwards; Daniel W Nebert; James M Woods; Aaron Barchowsky; William D Atchison
Journal:  Toxicol Sci       Date:  2007-10-18       Impact factor: 4.849

5.  Mechanisms pertaining to arsenic toxicity.

Authors:  Amrit Pal Singh; Rajesh Kumar Goel; Tajpreet Kaur
Journal:  Toxicol Int       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.